nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—ADRB1—obesity	0.246	0.543	CbGaD
Carteolol—ADRB2—obesity	0.207	0.457	CbGaD
Carteolol—ADRB2—Phenylpropanolamine—obesity	0.142	0.351	CbGbCtD
Carteolol—ADRB1—Phenylpropanolamine—obesity	0.14	0.346	CbGbCtD
Carteolol—CYP2D6—Phentermine—obesity	0.0373	0.0924	CbGbCtD
Carteolol—CYP2D6—Bupropion—obesity	0.0317	0.0785	CbGbCtD
Carteolol—CYP2D6—Methamphetamine—obesity	0.0298	0.0738	CbGbCtD
Carteolol—CYP2D6—Cimetidine—obesity	0.0233	0.0576	CbGbCtD
Carteolol—Block heart—Cimetidine—obesity	0.003	0.038	CcSEcCtD
Carteolol—Diabetic—Orlistat—obesity	0.00282	0.0357	CcSEcCtD
Carteolol—Night blindness—Topiramate—obesity	0.00214	0.0272	CcSEcCtD
Carteolol—Cerebral ischaemia—Sibutramine—obesity	0.00188	0.0238	CcSEcCtD
Carteolol—Atrioventricular block—Cimetidine—obesity	0.00175	0.0222	CcSEcCtD
Carteolol—Cerebrovascular accident—Phentermine—obesity	0.00152	0.0193	CcSEcCtD
Carteolol—Diabetic—Topiramate—obesity	0.00151	0.0192	CcSEcCtD
Carteolol—Cerebrovascular accident—Diethylpropion—obesity	0.00133	0.0168	CcSEcCtD
Carteolol—Palpitations—Methamphetamine—obesity	0.00111	0.014	CcSEcCtD
Carteolol—Palpitations—Benzphetamine—obesity	0.00107	0.0135	CcSEcCtD
Carteolol—Vision blurred—Phendimetrazine—obesity	0.00104	0.0131	CcSEcCtD
Carteolol—Palpitations—Phendimetrazine—obesity	0.000972	0.0123	CcSEcCtD
Carteolol—Arrhythmia—Phenylpropanolamine—obesity	0.000964	0.0122	CcSEcCtD
Carteolol—Insomnia—Methamphetamine—obesity	0.000924	0.0117	CcSEcCtD
Carteolol—Insomnia—Benzphetamine—obesity	0.000891	0.0113	CcSEcCtD
Carteolol—Vision blurred—Phenylpropanolamine—obesity	0.000885	0.0112	CcSEcCtD
Carteolol—Bradycardia—Cimetidine—obesity	0.00087	0.011	CcSEcCtD
Carteolol—Lacrimation increased—Bupropion—obesity	0.00086	0.0109	CcSEcCtD
Carteolol—Insomnia—Phendimetrazine—obesity	0.000812	0.0103	CcSEcCtD
Carteolol—Arrhythmia—Diethylpropion—obesity	0.000803	0.0102	CcSEcCtD
Carteolol—Palpitations—Phentermine—obesity	0.000794	0.0101	CcSEcCtD
Carteolol—Diabetes mellitus—Orlistat—obesity	0.000784	0.00993	CcSEcCtD
Carteolol—Diabetes mellitus—Sibutramine—obesity	0.000759	0.00961	CcSEcCtD
Carteolol—Hypersensitivity—Methamphetamine—obesity	0.000752	0.00953	CcSEcCtD
Carteolol—Photophobia—Bupropion—obesity	0.000744	0.00943	CcSEcCtD
Carteolol—Vision blurred—Diethylpropion—obesity	0.000737	0.00934	CcSEcCtD
Carteolol—Oedema—Phentermine—obesity	0.000734	0.00929	CcSEcCtD
Carteolol—Cardiac failure congestive—Sibutramine—obesity	0.000728	0.00922	CcSEcCtD
Carteolol—Hypersensitivity—Benzphetamine—obesity	0.000726	0.00919	CcSEcCtD
Carteolol—Hypotension—Phenylpropanolamine—obesity	0.000716	0.00907	CcSEcCtD
Carteolol—Hypoglycaemia—Orlistat—obesity	0.000699	0.00885	CcSEcCtD
Carteolol—Insomnia—Phenylpropanolamine—obesity	0.000693	0.00878	CcSEcCtD
Carteolol—Palpitations—Diethylpropion—obesity	0.000691	0.00875	CcSEcCtD
Carteolol—Dyspnoea—Phenylpropanolamine—obesity	0.000684	0.00866	CcSEcCtD
Carteolol—Hypoglycaemia—Sibutramine—obesity	0.000677	0.00857	CcSEcCtD
Carteolol—Dizziness—Methamphetamine—obesity	0.000675	0.00855	CcSEcCtD
Carteolol—Cerebrovascular accident—Sibutramine—obesity	0.000674	0.00853	CcSEcCtD
Carteolol—Insomnia—Phentermine—obesity	0.000664	0.0084	CcSEcCtD
Carteolol—Dizziness—Benzphetamine—obesity	0.000651	0.00825	CcSEcCtD
Carteolol—Headache—Methamphetamine—obesity	0.00064	0.0081	CcSEcCtD
Carteolol—Headache—Benzphetamine—obesity	0.000617	0.00781	CcSEcCtD
Carteolol—Visual disturbance—Bupropion—obesity	0.000607	0.00769	CcSEcCtD
Carteolol—Dizziness—Phendimetrazine—obesity	0.000594	0.00752	CcSEcCtD
Carteolol—Hypoglycaemia—Bupropion—obesity	0.00059	0.00747	CcSEcCtD
Carteolol—Cerebrovascular accident—Bupropion—obesity	0.000587	0.00744	CcSEcCtD
Carteolol—Nausea—Benzphetamine—obesity	0.000585	0.00741	CcSEcCtD
Carteolol—Bronchospasm—Orlistat—obesity	0.00058	0.00735	CcSEcCtD
Carteolol—Insomnia—Diethylpropion—obesity	0.000577	0.00731	CcSEcCtD
Carteolol—Diplopia—Bupropion—obesity	0.000576	0.00729	CcSEcCtD
Carteolol—Dyspnoea—Diethylpropion—obesity	0.000569	0.00721	CcSEcCtD
Carteolol—Hypersensitivity—Phenylpropanolamine—obesity	0.000565	0.00715	CcSEcCtD
Carteolol—Headache—Phendimetrazine—obesity	0.000562	0.00712	CcSEcCtD
Carteolol—Lacrimation increased—Topiramate—obesity	0.000548	0.00694	CcSEcCtD
Carteolol—Nausea—Phendimetrazine—obesity	0.000533	0.00675	CcSEcCtD
Carteolol—Asthenia—Phentermine—obesity	0.000526	0.00667	CcSEcCtD
Carteolol—Depression—Orlistat—obesity	0.000524	0.00664	CcSEcCtD
Carteolol—Atrioventricular block—Topiramate—obesity	0.000521	0.0066	CcSEcCtD
Carteolol—Nadolol—ADRB3—obesity	0.000511	0.0907	CrCbGaD
Carteolol—Depression—Sibutramine—obesity	0.000507	0.00643	CcSEcCtD
Carteolol—Dizziness—Phenylpropanolamine—obesity	0.000507	0.00642	CcSEcCtD
Carteolol—Conjunctivitis—Sibutramine—obesity	0.000495	0.00626	CcSEcCtD
Carteolol—Sinusitis—Orlistat—obesity	0.000493	0.00625	CcSEcCtD
Carteolol—Bronchospasm—Bupropion—obesity	0.000489	0.0062	CcSEcCtD
Carteolol—Bupranolol—ADRB3—obesity	0.000488	0.0866	CrCbGaD
Carteolol—Dizziness—Phentermine—obesity	0.000485	0.00614	CcSEcCtD
Carteolol—Sinusitis—Sibutramine—obesity	0.000477	0.00605	CcSEcCtD
Carteolol—Photophobia—Topiramate—obesity	0.000474	0.00601	CcSEcCtD
Carteolol—Bopindolol—ADRB3—obesity	0.000468	0.083	CrCbGaD
Carteolol—Bradycardia—Sibutramine—obesity	0.000465	0.00589	CcSEcCtD
Carteolol—Headache—Phentermine—obesity	0.00046	0.00582	CcSEcCtD
Carteolol—Nausea—Phenylpropanolamine—obesity	0.000455	0.00577	CcSEcCtD
Carteolol—Hypersensitivity—Cimetidine—obesity	0.000447	0.00567	CcSEcCtD
Carteolol—Visual impairment—Sibutramine—obesity	0.00044	0.00557	CcSEcCtD
Carteolol—Nausea—Phentermine—obesity	0.000436	0.00552	CcSEcCtD
Carteolol—Asthenia—Cimetidine—obesity	0.000436	0.00552	CcSEcCtD
Carteolol—Conjunctivitis—Bupropion—obesity	0.000431	0.00546	CcSEcCtD
Carteolol—Dizziness—Diethylpropion—obesity	0.000422	0.00535	CcSEcCtD
Carteolol—Diabetes mellitus—Topiramate—obesity	0.000422	0.00534	CcSEcCtD
Carteolol—Sinusitis—Bupropion—obesity	0.000416	0.00527	CcSEcCtD
Carteolol—Arrhythmia—Sibutramine—obesity	0.000408	0.00517	CcSEcCtD
Carteolol—Dysgeusia—Orlistat—obesity	0.000402	0.0051	CcSEcCtD
Carteolol—Dizziness—Cimetidine—obesity	0.000402	0.00509	CcSEcCtD
Carteolol—Headache—Diethylpropion—obesity	0.0004	0.00506	CcSEcCtD
Carteolol—Dysgeusia—Sibutramine—obesity	0.000389	0.00493	CcSEcCtD
Carteolol—Vision blurred—Orlistat—obesity	0.000387	0.0049	CcSEcCtD
Carteolol—Visual disturbance—Topiramate—obesity	0.000387	0.0049	CcSEcCtD
Carteolol—Visual impairment—Bupropion—obesity	0.000384	0.00486	CcSEcCtD
Carteolol—Headache—Cimetidine—obesity	0.00038	0.00482	CcSEcCtD
Carteolol—Nausea—Diethylpropion—obesity	0.000379	0.0048	CcSEcCtD
Carteolol—Hypoglycaemia—Topiramate—obesity	0.000376	0.00476	CcSEcCtD
Carteolol—Vision blurred—Sibutramine—obesity	0.000375	0.00475	CcSEcCtD
Carteolol—Diplopia—Topiramate—obesity	0.000367	0.00464	CcSEcCtD
Carteolol—Palpitations—Orlistat—obesity	0.000363	0.0046	CcSEcCtD
Carteolol—Nausea—Cimetidine—obesity	0.000361	0.00457	CcSEcCtD
Carteolol—Syncope—Sibutramine—obesity	0.000357	0.00452	CcSEcCtD
Carteolol—Arrhythmia—Bupropion—obesity	0.000356	0.00451	CcSEcCtD
Carteolol—Palpitations—Sibutramine—obesity	0.000351	0.00445	CcSEcCtD
Carteolol—Loss of consciousness—Sibutramine—obesity	0.000349	0.00443	CcSEcCtD
Carteolol—Dysgeusia—Bupropion—obesity	0.000339	0.0043	CcSEcCtD
Carteolol—Oedema—Orlistat—obesity	0.000335	0.00425	CcSEcCtD
Carteolol—Vision blurred—Bupropion—obesity	0.000327	0.00414	CcSEcCtD
Carteolol—Oedema—Sibutramine—obesity	0.000325	0.00411	CcSEcCtD
Carteolol—Pindolol—ADRB3—obesity	0.000322	0.0571	CrCbGaD
Carteolol—Shock—Sibutramine—obesity	0.000319	0.00404	CcSEcCtD
Carteolol—Syncope—Bupropion—obesity	0.000311	0.00394	CcSEcCtD
Carteolol—Palpitations—Bupropion—obesity	0.000306	0.00388	CcSEcCtD
Carteolol—Levobunolol—ADRB1—obesity	0.000305	0.0541	CrCbGaD
Carteolol—Loss of consciousness—Bupropion—obesity	0.000305	0.00386	CcSEcCtD
Carteolol—Insomnia—Orlistat—obesity	0.000303	0.00384	CcSEcCtD
Carteolol—Hypotension—Sibutramine—obesity	0.000303	0.00384	CcSEcCtD
Carteolol—Insomnia—Sibutramine—obesity	0.000293	0.00372	CcSEcCtD
Carteolol—Dyspnoea—Sibutramine—obesity	0.000289	0.00366	CcSEcCtD
Carteolol—Oedema—Bupropion—obesity	0.000283	0.00358	CcSEcCtD
Carteolol—Depression—Topiramate—obesity	0.000282	0.00357	CcSEcCtD
Carteolol—Shock—Bupropion—obesity	0.000278	0.00352	CcSEcCtD
Carteolol—Conjunctivitis—Topiramate—obesity	0.000275	0.00348	CcSEcCtD
Carteolol—Sinusitis—Topiramate—obesity	0.000265	0.00336	CcSEcCtD
Carteolol—Hypotension—Bupropion—obesity	0.000264	0.00335	CcSEcCtD
Carteolol—Bradycardia—Topiramate—obesity	0.000258	0.00327	CcSEcCtD
Carteolol—Levobunolol—ADRB2—obesity	0.000257	0.0455	CrCbGaD
Carteolol—Insomnia—Bupropion—obesity	0.000256	0.00324	CcSEcCtD
Carteolol—Dyspnoea—Bupropion—obesity	0.000252	0.00319	CcSEcCtD
Carteolol—Hypersensitivity—Orlistat—obesity	0.000247	0.00313	CcSEcCtD
Carteolol—Visual impairment—Topiramate—obesity	0.000244	0.0031	CcSEcCtD
Carteolol—Asthenia—Orlistat—obesity	0.000241	0.00305	CcSEcCtD
Carteolol—Hypersensitivity—Sibutramine—obesity	0.000239	0.00303	CcSEcCtD
Carteolol—Bopindolol—HTR1B—obesity	0.000239	0.0424	CrCbGaD
Carteolol—Asthenia—Sibutramine—obesity	0.000233	0.00295	CcSEcCtD
Carteolol—Nadolol—ADRB1—obesity	0.000231	0.041	CrCbGaD
Carteolol—Penbutolol—HTR1B—obesity	0.000228	0.0405	CrCbGaD
Carteolol—Dizziness—Orlistat—obesity	0.000222	0.00281	CcSEcCtD
Carteolol—Bupranolol—ADRB1—obesity	0.000221	0.0391	CrCbGaD
Carteolol—Dysgeusia—Topiramate—obesity	0.000216	0.00274	CcSEcCtD
Carteolol—Dizziness—Sibutramine—obesity	0.000215	0.00272	CcSEcCtD
Carteolol—Bopindolol—ADRB1—obesity	0.000211	0.0375	CrCbGaD
Carteolol—Headache—Orlistat—obesity	0.00021	0.00266	CcSEcCtD
Carteolol—Hypersensitivity—Bupropion—obesity	0.000208	0.00264	CcSEcCtD
Carteolol—Vision blurred—Topiramate—obesity	0.000208	0.00264	CcSEcCtD
Carteolol—Salbutamol—ADRB1—obesity	0.000207	0.0368	CrCbGaD
Carteolol—Headache—Sibutramine—obesity	0.000203	0.00257	CcSEcCtD
Carteolol—Asthenia—Bupropion—obesity	0.000203	0.00257	CcSEcCtD
Carteolol—Penbutolol—ADRB1—obesity	0.000202	0.0358	CrCbGaD
Carteolol—Nausea—Orlistat—obesity	0.000199	0.00252	CcSEcCtD
Carteolol—Syncope—Topiramate—obesity	0.000198	0.00251	CcSEcCtD
Carteolol—Palpitations—Topiramate—obesity	0.000195	0.00247	CcSEcCtD
Carteolol—Nadolol—ADRB2—obesity	0.000194	0.0345	CrCbGaD
Carteolol—Loss of consciousness—Topiramate—obesity	0.000194	0.00246	CcSEcCtD
Carteolol—Nausea—Sibutramine—obesity	0.000193	0.00244	CcSEcCtD
Carteolol—Dizziness—Bupropion—obesity	0.000187	0.00237	CcSEcCtD
Carteolol—Bupranolol—ADRB2—obesity	0.000185	0.0329	CrCbGaD
Carteolol—Oedema—Topiramate—obesity	0.00018	0.00228	CcSEcCtD
Carteolol—Bopindolol—ADRB2—obesity	0.000178	0.0316	CrCbGaD
Carteolol—Shock—Topiramate—obesity	0.000177	0.00225	CcSEcCtD
Carteolol—Headache—Bupropion—obesity	0.000177	0.00224	CcSEcCtD
Carteolol—Propranolol—ADRB3—obesity	0.000175	0.0311	CrCbGaD
Carteolol—Salbutamol—ADRB2—obesity	0.000174	0.0309	CrCbGaD
Carteolol—Penbutolol—ADRB2—obesity	0.00017	0.0301	CrCbGaD
Carteolol—Hypotension—Topiramate—obesity	0.000168	0.00213	CcSEcCtD
Carteolol—Nausea—Bupropion—obesity	0.000168	0.00213	CcSEcCtD
Carteolol—Pindolol—HTR1B—obesity	0.000164	0.0292	CrCbGaD
Carteolol—Insomnia—Topiramate—obesity	0.000163	0.00206	CcSEcCtD
Carteolol—Dyspnoea—Topiramate—obesity	0.000161	0.00204	CcSEcCtD
Carteolol—Pindolol—ADRB1—obesity	0.000145	0.0258	CrCbGaD
Carteolol—Hypersensitivity—Topiramate—obesity	0.000133	0.00168	CcSEcCtD
Carteolol—Asthenia—Topiramate—obesity	0.000129	0.00164	CcSEcCtD
Carteolol—Pindolol—ADRB2—obesity	0.000122	0.0217	CrCbGaD
Carteolol—Dizziness—Topiramate—obesity	0.000119	0.00151	CcSEcCtD
Carteolol—Headache—Topiramate—obesity	0.000113	0.00143	CcSEcCtD
Carteolol—Nausea—Topiramate—obesity	0.000107	0.00136	CcSEcCtD
Carteolol—Propranolol—HTR1B—obesity	8.97e-05	0.0159	CrCbGaD
Carteolol—Propranolol—ADRB1—obesity	7.93e-05	0.0141	CrCbGaD
Carteolol—Propranolol—ADRB2—obesity	6.67e-05	0.0118	CrCbGaD
Carteolol—ADRB1—Signaling Pathways—DRD1—obesity	1.29e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR2C—obesity	1.29e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NPS—obesity	1.28e-05	0.000219	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AGT—obesity	1.27e-05	0.000217	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—F2—obesity	1.26e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PRKCB—obesity	1.26e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DRD1—obesity	1.26e-05	0.000215	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR2C—obesity	1.26e-05	0.000215	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NTRK2—obesity	1.25e-05	0.000214	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—UCP3—obesity	1.24e-05	0.000213	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD11B1—obesity	1.24e-05	0.000213	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ECHS1—obesity	1.24e-05	0.000213	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—UCP2—obesity	1.24e-05	0.000213	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AGT—obesity	1.24e-05	0.000212	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CG—obesity	1.23e-05	0.000211	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NTRK2—obesity	1.22e-05	0.000209	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ADH1B—obesity	1.22e-05	0.000209	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GHRL—obesity	1.22e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PARP1—obesity	1.22e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRB1—obesity	1.22e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DRD4—obesity	1.21e-05	0.000207	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CG—obesity	1.21e-05	0.000206	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPAM—obesity	1.21e-05	0.000206	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ACSL1—obesity	1.21e-05	0.000206	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARGC1B—obesity	1.21e-05	0.000206	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PARP1—obesity	1.19e-05	0.000204	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GHRL—obesity	1.19e-05	0.000204	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DRD4—obesity	1.18e-05	0.000202	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—POMC—obesity	1.18e-05	0.000201	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PRKCB—obesity	1.17e-05	0.0002	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—F2—obesity	1.17e-05	0.0002	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PCK1—obesity	1.17e-05	0.0002	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HADH—obesity	1.17e-05	0.0002	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—FADS1—obesity	1.17e-05	0.0002	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CNR1—obesity	1.16e-05	0.000197	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—POMC—obesity	1.15e-05	0.000196	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—F2—obesity	1.15e-05	0.000196	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PRKCB—obesity	1.15e-05	0.000196	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ACP5—obesity	1.14e-05	0.000194	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TCF7L2—obesity	1.13e-05	0.000194	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CNR1—obesity	1.13e-05	0.000193	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT2—obesity	1.13e-05	0.000193	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DRD2—obesity	1.13e-05	0.000193	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CG—obesity	1.12e-05	0.000192	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GCG—obesity	1.12e-05	0.000191	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTPN1—obesity	1.12e-05	0.000191	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TCF7L2—obesity	1.11e-05	0.00019	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—G6PD—obesity	1.11e-05	0.00019	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT2—obesity	1.11e-05	0.000189	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DRD2—obesity	1.1e-05	0.000188	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CG—obesity	1.1e-05	0.000187	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HK1—obesity	1.1e-05	0.000187	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SREBF2—obesity	1.1e-05	0.000187	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GCG—obesity	1.09e-05	0.000186	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTPN1—obesity	1.09e-05	0.000186	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	1.09e-05	0.000185	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—POMC—obesity	1.07e-05	0.000182	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRL—obesity	1.06e-05	0.000182	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	1.06e-05	0.000181	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPA—obesity	1.06e-05	0.000181	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STK11—obesity	1.05e-05	0.000179	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL2—obesity	1.04e-05	0.000178	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—POMC—obesity	1.04e-05	0.000178	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRL—obesity	1.04e-05	0.000178	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLG—obesity	1.04e-05	0.000177	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—RHOA—obesity	1.04e-05	0.000177	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPIN1—obesity	1.04e-05	0.000177	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STK11—obesity	1.03e-05	0.000175	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT2—obesity	1.03e-05	0.000175	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	1.02e-05	0.000175	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL2—obesity	1.02e-05	0.000175	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLG—obesity	1.01e-05	0.000173	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA5—obesity	1.01e-05	0.000173	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—RHOA—obesity	1.01e-05	0.000173	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FOXO3—obesity	1.01e-05	0.000173	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRB2—obesity	1.01e-05	0.000173	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT2—obesity	1e-05	0.000171	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	1e-05	0.000171	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SOCS1—obesity	9.94e-06	0.00017	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FOXO3—obesity	9.9e-06	0.000169	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CD—obesity	9.86e-06	0.000168	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SOCS3—obesity	9.82e-06	0.000168	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SOCS1—obesity	9.73e-06	0.000166	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CLOCK—obesity	9.68e-06	0.000165	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC22A1—obesity	9.68e-06	0.000165	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CD—obesity	9.64e-06	0.000165	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNB3—obesity	9.62e-06	0.000164	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SOCS3—obesity	9.61e-06	0.000164	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—TYK2—obesity	9.48e-06	0.000162	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	9.46e-06	0.000162	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF2—obesity	9.45e-06	0.000161	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GLP1R—obesity	9.43e-06	0.000161	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SULT2A1—obesity	9.43e-06	0.000161	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNB3—obesity	9.41e-06	0.000161	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—RHOA—obesity	9.4e-06	0.000161	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNAS—obesity	9.36e-06	0.00016	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3R1—obesity	9.31e-06	0.000159	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DPYD—obesity	9.28e-06	0.000159	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—TYK2—obesity	9.28e-06	0.000158	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	9.25e-06	0.000158	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF2—obesity	9.24e-06	0.000158	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—RHOA—obesity	9.2e-06	0.000157	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOB—obesity	9.17e-06	0.000157	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNAS—obesity	9.16e-06	0.000156	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3R1—obesity	9.1e-06	0.000156	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOB—obesity	8.97e-06	0.000153	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL5—obesity	8.95e-06	0.000153	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PRKAR2B—obesity	8.93e-06	0.000153	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DCN—obesity	8.87e-06	0.000151	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL5—obesity	8.76e-06	0.00015	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LPL—obesity	8.76e-06	0.00015	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FOXO1—obesity	8.69e-06	0.000149	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	8.68e-06	0.000148	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CPT1A—obesity	8.63e-06	0.000147	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	8.59e-06	0.000147	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LPL—obesity	8.56e-06	0.000146	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FOXO1—obesity	8.5e-06	0.000145	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	8.49e-06	0.000145	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NAMPT—obesity	8.46e-06	0.000145	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCK—obesity	8.41e-06	0.000144	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LIPC—obesity	8.41e-06	0.000144	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	8.4e-06	0.000144	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOC3—obesity	8.35e-06	0.000143	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CETP—obesity	8.11e-06	0.000139	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCD—obesity	8.07e-06	0.000138	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SDC1—obesity	8.02e-06	0.000137	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR2A—obesity	7.89e-06	0.000135	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCD—obesity	7.89e-06	0.000135	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKR1C3—obesity	7.89e-06	0.000135	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—C3—obesity	7.88e-06	0.000135	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SCARB1—obesity	7.77e-06	0.000133	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR2A—obesity	7.72e-06	0.000132	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—C3—obesity	7.71e-06	0.000132	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SREBF1—obesity	7.54e-06	0.000129	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IRS2—obesity	7.5e-06	0.000128	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGT—obesity	7.49e-06	0.000128	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LEP—obesity	7.34e-06	0.000125	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOE—obesity	7.34e-06	0.000125	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IRS2—obesity	7.34e-06	0.000125	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GOT2—obesity	7.33e-06	0.000125	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGT—obesity	7.33e-06	0.000125	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CAV1—obesity	7.27e-06	0.000124	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOA1—obesity	7.25e-06	0.000124	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LEP—obesity	7.18e-06	0.000123	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOE—obesity	7.18e-06	0.000123	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—FASN—obesity	7.18e-06	0.000123	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—BCHE—obesity	7.15e-06	0.000122	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CAV1—obesity	7.11e-06	0.000122	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOA1—obesity	7.1e-06	0.000121	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ESR1—obesity	7.01e-06	0.00012	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—F2—obesity	6.92e-06	0.000118	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCB—obesity	6.92e-06	0.000118	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2E1—obesity	6.9e-06	0.000118	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ESR1—obesity	6.85e-06	0.000117	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BAD—obesity	6.84e-06	0.000117	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NQO1—obesity	6.82e-06	0.000116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—F2—obesity	6.77e-06	0.000116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCB—obesity	6.77e-06	0.000116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BAD—obesity	6.69e-06	0.000114	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CG—obesity	6.62e-06	0.000113	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IRS1—obesity	6.55e-06	0.000112	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCG—obesity	6.54e-06	0.000112	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A4—obesity	6.54e-06	0.000112	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CG—obesity	6.48e-06	0.000111	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYCS—obesity	6.45e-06	0.00011	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IRS1—obesity	6.4e-06	0.000109	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GOT1—obesity	6.33e-06	0.000108	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GGT1—obesity	6.33e-06	0.000108	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—POMC—obesity	6.3e-06	0.000108	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INS—obesity	6.27e-06	0.000107	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOA1—obesity	6.24e-06	0.000107	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL2—obesity	6.17e-06	0.000105	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—POMC—obesity	6.17e-06	0.000105	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—STK11—obesity	6.15e-06	0.000105	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP19A1—obesity	6.15e-06	0.000105	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INS—obesity	6.13e-06	0.000105	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1—obesity	6.06e-06	0.000104	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT2—obesity	6.06e-06	0.000104	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL2—obesity	6.03e-06	0.000103	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1—obesity	5.93e-06	0.000101	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT2—obesity	5.93e-06	0.000101	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CD—obesity	5.82e-06	9.95e-05	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	5.77e-06	9.85e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SERPINE1—obesity	5.76e-06	9.84e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—COMT—obesity	5.71e-06	9.76e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CD—obesity	5.7e-06	9.73e-05	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	5.64e-06	9.64e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARGC1A—obesity	5.63e-06	9.63e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GNB3—obesity	5.63e-06	9.63e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SERPINE1—obesity	5.63e-06	9.63e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—obesity	5.61e-06	9.58e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TYK2—obesity	5.6e-06	9.57e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RHOA—obesity	5.56e-06	9.49e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOS3—obesity	5.5e-06	9.39e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3R1—obesity	5.5e-06	9.39e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GNAS—obesity	5.49e-06	9.37e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TYK2—obesity	5.48e-06	9.36e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RHOA—obesity	5.43e-06	9.29e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3R1—obesity	5.38e-06	9.19e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOS3—obesity	5.38e-06	9.19e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOB—obesity	5.37e-06	9.18e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	5.24e-06	8.95e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPL—obesity	5.13e-06	8.76e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	5.12e-06	8.75e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MTOR—obesity	5.08e-06	8.67e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CB—obesity	5.08e-06	8.67e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX1—obesity	5e-06	8.55e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CB—obesity	4.96e-06	8.48e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MTOR—obesity	4.96e-06	8.48e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CD36—obesity	4.87e-06	8.33e-05	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—obesity	4.71e-06	8.05e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—obesity	4.64e-06	7.92e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—obesity	4.62e-06	7.89e-05	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—obesity	4.61e-06	7.87e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—obesity	4.54e-06	7.75e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARA—obesity	4.53e-06	7.74e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—obesity	4.41e-06	7.54e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AGT—obesity	4.39e-06	7.5e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—obesity	4.32e-06	7.37e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOE—obesity	4.3e-06	7.35e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK8—obesity	4.29e-06	7.33e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—obesity	4.28e-06	7.31e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAV1—obesity	4.26e-06	7.28e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA1—obesity	4.25e-06	7.26e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK8—obesity	4.2e-06	7.17e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—obesity	4.19e-06	7.15e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT3—obesity	3.92e-06	6.7e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CG—obesity	3.88e-06	6.63e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT3—obesity	3.84e-06	6.56e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—obesity	3.75e-06	6.4e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—POMC—obesity	3.69e-06	6.31e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—INS—obesity	3.67e-06	6.28e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MYC—obesity	3.64e-06	6.23e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFB1—obesity	3.64e-06	6.21e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MYC—obesity	3.57e-06	6.09e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFB1—obesity	3.56e-06	6.08e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CD—obesity	3.41e-06	5.83e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—obesity	3.37e-06	5.75e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3R1—obesity	3.22e-06	5.5e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NOS3—obesity	3.22e-06	5.5e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CA—obesity	3.09e-06	5.29e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CA—obesity	3.03e-06	5.17e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CB—obesity	2.97e-06	5.08e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—obesity	2.95e-06	5.03e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—obesity	2.74e-06	4.68e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—obesity	2.68e-06	4.58e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—obesity	2.53e-06	4.32e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—obesity	2.47e-06	4.22e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CA—obesity	1.81e-06	3.1e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—obesity	1.48e-06	2.53e-05	CbGpPWpGaD
